EUpolicy

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

Market Access

The EU Joint Clinical Assessment in practice: Early lessons

Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.

Market Access

Europe’s new HTA reality: The JCA, one year on

Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.

News

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.

Market Access

Three separate injections - blue, red, and yellow - take off against black background

Why global pharmaceutical reforms are quietly redirecting ra...

Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs

News

EU seeks advice on Sanofi's response to mismarketing claim

The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine.

Europe for life sciences and for patients, with BeOne Medici...

The EU Joint Clinical Assessment in practice: Early lessons

Europe’s new HTA reality: The JCA, one year on

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

Why global pharmaceutical reforms are quietly redirecting ra...

EU seeks advice on Sanofi's response to mismarketing claim

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

EUpolicy

Editor's Picks